Literature DB >> 1908852

Risk of gastric remnant cancer in Japan.

S Tokudome.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1908852      PMCID： PMC5918548          DOI： 10.1111/j.1349-7006.1991.tb02715.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


× No keyword cloud information.
  8 in total

1.  [Cancer risk of the stomach resected for ulcer. The role of duodenogastric reflux (author's transl)].

Authors:  K Dahm; R Eichen; H Mitschke
Journal:  Langenbecks Arch Chir       Date:  1977-11-04

2.  Stomach cancer following gastric surgery for benign conditions.

Authors:  H Stalsberg; S Taksdal
Journal:  Lancet       Date:  1971-11-27       Impact factor: 79.321

3.  Are nitrite and N-nitroso compounds in gastric juice risk factors for carcinoma in the operated stomach?

Authors:  P Schlag; R Böckler; H Ulrich; M Peter; P Merkle; C Herfarth
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

4.  Mortality from gastric cancer following gastric surgery for peptic ulcer.

Authors:  C P Caygill; M J Hill; J S Kirkham; T C Northfield
Journal:  Lancet       Date:  1986-04-26       Impact factor: 79.321

5.  The long-term prognosis of patients gastrectomized for benign gastroduodenal diseases.

Authors:  A Asano; S Mizuno; R Sasaki; K Aoki; H Yokoyama; Y Yokoyama
Journal:  Jpn J Cancer Res       Date:  1987-04

6.  A prospective study on primary gastric stump cancer following partial gastrectomy for benign gastroduodenal diseases.

Authors:  S Tokudome; S Kono; M Ikeda; M Kuratsune; C Sano; K Inokuchi; Y Kodama; H Ichimiya; F Nakayama; N Kaibara
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

7.  Stomach cancer after partial gastrectomy for benign ulcer disease.

Authors:  G Lundegårdh; H O Adami; C Helmick; M Zack; O Meirik
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

8.  Risk of carcinoma following gastric operations for benign disease. A historical cohort study of 3470 patients.

Authors:  A Viste; E Bjørnestad; P Opheim; A Skarstein; J Thunold; F Hartveit; G E Eide; T J Eide; O Søreide
Journal:  Lancet       Date:  1986-08-30       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.